Approval · Notice of Compliance 27649 · 2022
CEPHALEXIN: Notice of Compliance 27649
Issued February 22, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27649
- Date
- February 22, 2022
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updated labelling materials. Administrative: Labelling Update (to Match Licensor)
- Canadian reference product
- KEFLEX (Pendopharm Division Of Pharmascience Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEPHALEXIN | Not yet assigned | — |
Medicinal ingredients
- CEPHALEXIN MONOHYDRATE 500 MG per TAB